New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) – Butlletí de la Recerca

New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)

by biblioteca on 21 de setembre de 2026 with No hi ha comentaris

New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Convoca: Pfizer Inc
Termini: 21/10/2026

Deixa un comentari Cancel·la les respostes